Efficacy and Immunological Impact of Intrathecal Baclofen Pumps in Managing Spasticity in Multiple Sclerosis in Adult Patients: A Systematic Review
Sclerosis · 14.01.2025 · 3 (1) · 2
DOI: 10.3390/sclerosis3010002 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Sclerosis, online erschienen am 14.01.2025. Verfasst von Billy McBenedict und 8 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Multiple sclerosis (MS) is a chronic autoimmune disease marked by inflammatory demyelination in the central nervous system, leading to debilitating spasticity. Managing spasticity in MS remains a challenge, and intrathecal baclofen (ITB) therapy has emerged as a potential targeted treatment. This systematic review investigated the efficacy of ITB pumps in managing MS-related spasticity and explored their immunomodulatory effects.
Methods
This review adhered to PRISMA guidelines and was submitted for registration retrospectively with the Open Science Foundation. A comprehensive literature search was conducted in PubMed, Embase, Scopus, and Web of Science from January 2013 to August 2024. Studies were included if they examined adult MS patients receiving ITB for spasticity, reporting outcomes related to spasticity and quality of life. Risk of bias was assessed using the Joanna Briggs Institute Critical Appraisal Tools, and findings were synthesized narratively.
Results
Eight studies (n = 723 participants) met inclusion criteria. ITB was associated with significant reductions in spasticity severity and improvements in quality of life, with reduced reliance on oral antispasticity medications. Immunologically, ITB has demonstrated potential in modulating inflammatory pathways, downregulating pro-inflammatory cytokines, and shifting immune responses toward an anti-inflammatory profile. Common complications included catheter-related issues and infections, with low overall complication rates. Sensitivity analyses indicated robustness in outcomes across higher-quality studies.
Conclusions
ITB pumps are effective in controlling spasticity and offer additional immunological benefits for MS patients. Further research should explore ITB’s long-term immunomodulatory effects and its potential in combined therapeutic strategies. The review was not financially supported, and no conflicts of interest were declared by the authors.
Zitieren
APA
McBenedict, B., Hauwanga, W., Pogodina, A., Devan, J. N., Goh, K. S., Yau, R. C. C., Alphonse, B., Adolphsson, L., & Pessôa, B. L. (2025). Efficacy and Immunological Impact of Intrathecal Baclofen Pumps in Managing Spasticity in Multiple Sclerosis in Adult Patients: A Systematic Review. Sclerosis, 3(1), 2. https://doi.org/10.3390/sclerosis3010002
Vancouver
McBenedict B, Hauwanga W, Pogodina A, Devan JN, Goh KS, Yau RCC, et al. Efficacy and Immunological Impact of Intrathecal Baclofen Pumps in Managing Spasticity in Multiple Sclerosis in Adult Patients: A Systematic Review. Sclerosis. 2025;3(1):2. doi:10.3390/sclerosis3010002
BibTeX
@article{McBenedict2025,
author = {McBenedict, Billy and Hauwanga, Wilhelmina and Pogodina, Anna and Devan, Jeshua Nathaniel and Goh, Kang Suen and Yau, Ryan Chun Chien and Alphonse, Berley and Adolphsson, Lorena and Pessôa, Bruno Lima},
title = {Efficacy and Immunological Impact of Intrathecal Baclofen Pumps in Managing Spasticity in Multiple Sclerosis in Adult Patients: A Systematic Review},
journal = {Sclerosis},
year = {2025},
volume = {3},
number = {1},
pages = {2},
doi = {10.3390/sclerosis3010002}
}
EUVIMED